Publication

Autoantibodies in long COVID: a mechanistic foothold in a heterogeneous disease

Wall, Emma C
; 
Richter, Alex G
Abstract
Long COVID is a heterogeneous, multi-system disease that poses challenges for patients, health systems, and economies. Two papers in Cell and Cell Reports Medicine from independent groups suggest that autoantibodies in a subset of long COVID patients can directly drive symptoms such as pain, fatigue, or neurocognitive problems.
MIDER Authors
Richter, Alex G
Affiliations
Citations
Google Scholar:
Lookup
Altmetric:
Date
2026-05-28
Type
Article
Subject
Long Covid
 Covid-19
 Antibodies
Collections
UHB Allergy and Immunology
Show all metadata
Citation
Wall EC, Richter AG. Autoantibodies in long COVID: A mechanistic foothold in a heterogeneous disease. Cell. 2026 May 28;189(11):3179-3180. doi: 10.1016/j.cell.2026.04.044.
Journal / Source Title
Cell
DOI
10.1016/j.cell.2026.04.044
URI
https://hdl.handle.net/20.500.14200/10566
PMID
42208496
Publisher
Cell Press
Publisher’s URL
https://www.sciencedirect.com/journal/cell
Publisher’s statement
Note / Copyright